
No. of Pages: 100 | Report Code: TIPRE00027147 | Category: Life Sciences
No. of Pages: 100 | Report Code: TIPRE00027147 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Sterile Compounding Pharmacies Market – By Product
1.3.2 North America Sterile Compounding Pharmacies Market – By Route of Administration
1.3.3 North America Sterile Compounding Pharmacies Market – By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5.1 Market Drivers
5.1.1 Rising Uptake of Personalized Medicines
5.1.2 Benefits of On-site Sterile Compounding
5.2 Market Restraints
5.2.1 Product Recalls and Stringent Regulatory Requirements
5.3 Market Opportunities
5.3.1 Development of Centralized or Regional Compounding Centers for Customized Formulation
5.4 Future Trends
5.4.1 Continued Support for Outsourcing Facilities and Manufacturing
5.5 Impact Analysis
6.1 North America Sterile Compounding Pharmacies Market Revenue Forecast and Analysis
7.1 Overview
7.2 North America Sterile Compounding Pharmacies Market, By Product, 2021 & 2028 (%)
7.3 Injectable Drugs
7.3.1 Overview
7.3.2 Injectable Drugs: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Infusions
7.4.1 Overview
7.4.2 Infusions: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
8.1 Overview
8.2 North America Sterile Compounding Pharmacies Market Share by Route of Administration - 2021 & 2028 (%)
8.3 Subcutaneous
8.3.1 Overview
8.3.2 Subcutaneous: North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
8.4 Intravenous
8.4.1 Overview
8.4.2 Intravenous: North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
8.5 Intramuscular
8.5.1 Overview
8.5.2 Intramuscular: North America Sterile Compounding Pharmacies Market Revenue and Forecast to 2028 (US$ Million)
9.1 North America: Sterile Compounding Pharmacies Market
9.1.1 Overview
9.1.3 North America: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)
9.1.3.1 US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.1.1 Overview
9.1.3.1.2 US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.1.3 US: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)
9.1.3.1.4 US: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)
9.1.3.2 Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.2.1 Overview
9.1.3.2.2 Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.2.3 Canada: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)
9.1.3.2.4 Canada: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)
9.1.3.3 Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.3.1 Overview
9.1.3.3.2 Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.3.3 Mexico: Sterile Compounding Pharmacies Market, by Product, 2019–2028 (US$ Million)
9.1.3.3.4 Mexico: Sterile Compounding Pharmacies Market, by Route of Administration, 2019–2028 (US$ Million)
10.1 North America: Impact Assessment of COVID-19 Pandemic
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12.1 Fagron, Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Triangle Compounding Pharmacy
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 B. Braun Melsungen AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Phar MEDium Healthcare Holdings, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fresenius Kabi AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Avella Specialty Pharmacy
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pencol Compounding Pharmacy
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Pavilion Compounding Pharmacy, LLC.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Pace Pharmacy
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 SandsRx
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13.1 About The Insight Partners
13.2 Glossary of Terms
Table 1. North America Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. US Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 4. Canada: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 6. Mexico: Sterile Compounding Pharmacies Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico Sterile Compounding Pharmacies Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)
Table 8. Organic Developments in the North America Sterile Compounding Pharmacies Market
Table 9. Inorganic Developments in the North America Sterile Compounding Pharmacies Market
Table 10. Glossary of Terms
Figure 1. North America Sterile Compounding Pharmacies Market Segmentation
Figure 2. North America Sterile Compounding Pharmacies Market, By Country
Figure 3. North America Sterile Compounding Pharmacies Market Overview
Figure 4. Injectable Drugs Segment Held Largest Share of Product Segment in North America Sterile Compounding Pharmacies Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints About North America Sterile Compounding Pharmacies Market
Figure 9. North America Sterile Compounding Pharmacies Market – Revenue Forecast and Analysis – 2020- 2028
Figure 10. North America Sterile Compounding Pharmacies Market, by Product, 2021 & 2028 (%)
Figure 11. Injectable Drugs: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Infusions: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. North America Sterile Compounding Pharmacies Market Share by Route of Administration - 2021 & 2028 (%)
Figure 14. Subcutaneous: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Intravenous: North America Sterile Compounding Pharmacies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. Intramuscular: North America Sterile Compounding Pharmacies Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. North America: Sterile Compounding Pharmacies Market, by Key Country – Revenue (2021) (US$ Million)
Figure 18. North America: Sterile Compounding Pharmacies Market, by Country, 2021 & 2028 (%)
Figure 19. US: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Canada: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Mexico: Sterile Compounding Pharmacies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Impact of COVID-19 Pandemic in North American Country Markets